Chester County News and Community Website
PHILADELPHIA, PA — The Wistar Institute has unveiled a groundbreaking approach to tackling ovarian cancer, potentially revolutionizing treatment outcomes for the deadliest of gynecological cancers. Led by Nan Zhang, Ph.D., …
Pioneering Discovery by The Wistar Institute Offers New Hope in Ovarian Cancer Treatment Read More
BERWYN, PA — Panavance Therapeutics Inc. has announced groundbreaking findings this week, demonstrating the potential of their investigational drug, misetionamide (GP-2250), to tackle various forms of cancer by directly inhibiting …
Panavance Therapeutics Unveils Promising Data on Misetionamide’s Dual Cancer Targeting Mechanism Read More
PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM), in collaboration with Moderna, Inc. (Nasdaq: MRNA), has announced promising pre-clinical results for their innovative anti-GPC3 chimeric antigen receptor macrophage (CAR-M) therapy targeting …
Carisma Therapeutics and Moderna Unveil Promising Pre-Clinical Data for Anti-GPC3 CAR-M Therapy Read More
DOWNINGTOWN, PA — Demonstrating a robust commitment to community service, Downingtown High School West‘s (DHSW) Pickleball Club successfully raised $460 for Bringing Hope Home, a local nonprofit dedicated to supporting …
Triumphant Teens Rally to Smash Cancer Costs: Downingtown’s Pickleball Heroes Light Up the Community! Read More PHILADELPHIA, PA — The Wistar Institute has made a significant breakthrough in understanding the role of Parkin, a protein traditionally associated with Parkinson’s disease, in the body’s immune response to cancer. …
Wistar Institute Breakthrough: Parkin Protein Revealed as a Game-Changer in Cancer Immunity! Read More
MALVERN, PA — BluePearl Malvern, part of BluePearl Pet Hospital, is at the forefront of veterinary cancer treatment with its exclusive use of the CyberKnife technology, a cutting-edge, non-invasive option for …
BluePearl Malvern Enhances Pet Cancer Care with Exclusive CyberKnife Technology Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) recently granted accelerated approval for a new treatment combination for adults with KRAS G12C-mutated locally advanced or metastatic colorectal cancer (CRC). …
FDA Grants Accelerated Approval to New Colorectal Cancer Treatment Read More
WASHINGTON, D.C. — On Monday, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) in combination with carboplatin and paclitaxel, followed by single-agent pembrolizumab, for adult patients with primary …
FDA Approves Keytruda Combination for Advanced Endometrial Cancer Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) announced a significant development in its ongoing ABOYA-119 clinical trial. The Safety Review Committee (SRC) has approved the commencement of dosing patients …
Aprea Therapeutics Advances Cancer Treatment Trial to Higher Dose Level Read More
WEST CHESTER, PA — Syapse, a real-world oncology data company, has introduced Syapse Cohorts: Essentials, a new tool aimed at providing cancer researchers and life sciences companies with comprehensive datasets. …
Syapse Launches New Oncology Data Tool to Aid Cancer Research Read More